05/28/2024
Keaton Langston, who owned, operated, had financial interests in, or was affiliated with pharmacies, durable medical equipment (DME) companies, and a laboratory, admitted his role in a health care fraud scheme that caused losses to Medicare in excess of $51 million. According to documents filed in the case and statements made in court, Langston and others used the previously mentioned organizations to defraud health care benefit programs by offering and paying kickbacks and bribes in exchange for doctors’ orders for DME, genetic cancer screening tests, and compounded medications. Claims for reimbursement were allegedly made without regard to medical necessity. Read a Department of Justice press release. Read an older story on Politico.